• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Norethindrone/Ethinyl Estradiol

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – June 2012

 

Summary View

 

Modicon (norethindrone/ethinyl estradiol) Tablets
Ortho-Cept (desogestrel and ethinyl estradiol) Tablets
Ortho-Cyclen (norgestimate/ethinyl estradiol) Tablets
Ortho Tri-Cyclen (norgestimate/ethinyl estradiol) Tablets
Ortho Tri-Cyclen Lo (norgestimate/ethinyl estradiol) Tablet
Ortho-Novum (norethindrone/ethinyl estradiol) 1/35 Tablets
Ortho-Novum (norethindrone/ethinyl estradiol) 7/7/7 Tablets
 
 

PRECAUTIONS

Drug Interactions
  • addition of a lamotrigine interaction